How high resolution FT-IR microscopy is improving tablet formulation across the pharmaceutical industry

CLICK TO LEARN

Analysis of microscopic contamination in pharmaceutical products

Mid-infrared (MIR) microscopy is a useful chemical identification tool that is used to complement traditional light microscopy. Since first coupling an infrared (IR) spectrometer to a microscope, the technique has enjoyed widespread use in a variety of research and industrial applications including the analysis of pharmaceuticals.

In practice, the light microscope is used to locate the region of interest and then it is non-invasively and non-destructively sampled with infrared radiation to provide chemical identification of the desired microscopic area within the sample thus identifying the constituent distribution or any contaminants. 

Comparison of scans from a paracetamol tablet with 5% w/w caffeine (top) and a counterfeit paracetamol tablet adulterated with 5% caffeine (bottom). Red areas represent caffeine distribution. 

With Innovative Thinking,
We Are Changing Things For The Better

Spectrum 3™

Spectrum 3™ Tablet Checker

Spectrum 3™ Accessories

Spotlight 400 FT-IR Microscope  and Spectrum 3™

CLICK TO LEARN

IR microscopy enables the industry to reduce manufacturing cycle times and product variability for shorter time-to-market and with fewer chances of product failures. You can utilize both standard mid-IR attenuated total reflection (ATR) imaging techniques and NIR direct reflectance to gain deeper insights into ingredient distribution in solid doses.

The PerkinElmer Spotlight™ IR microscope systems are designed to meet the challenges of the pharmaceutical industry by generating high-quality, reproducible data from a variety of sample types. The Spotlight 400 FT-IR imaging system combines high sensitivity and rapid imaging with ease-of-use. The ability to image large sample areas rapidly at high spatial resolution extends FT-IR microscopy into new applications. The Spotlight 400 FT-IR imaging system is designed with state-of-the-art technology to allow for intelligent automation and sophisticated analysis. Spotlight and Spectrum FT-IR instruments are 21 CRF 11 compliant and the software and installation services will make meeting regulatory requirements seamless.

CLICK TO LEARN how the Spotlight range of FT-IR Microscopes will help you to deliver better products more quickly.

FOLLOW US 

Go to article: Home | Waive goodbye to vaccine patentsGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: DatwylerGo to article: Datwyler Company InsightGo to article: LabcorpGo to article: Biesterfeld Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Dr. Paul LohmannGo to article: ButterworthGo to article: SkyepharmaGo to article: BaxterGo to article: CommentGo to article: Speeding up patient access to innovative drugsGo to article: The competitive landscape of neoantigen-targeting therapeutics in oncologyGo to article: Bacterial “cell factories”: an eco-friendly approach to chemical productionGo to article: MDR set to transform how MedTech firms approach content managementGo to article: PerkinElmerGo to article: NiproGo to article: NiproGo to article: In DepthGo to article: Should UK children be vaccinated against chickenpox?Go to article: Fighting India’s ‘black fungus’ epidemicGo to article: What could a vaccine patent waiver mean for pharma manufacturing? Go to article: Algae proteins: a vision of the futureGo to article: A brief history of ALS awareness and its sparse treatments Go to article: Ferring draws closer to a microbiome breakthroughGo to article: The Solubility companyGo to article: Myonex Go to article: Owen MumfordGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue